• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PENUMBRA, INC. POD COIL; HCG, KRD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PENUMBRA, INC. POD COIL; HCG, KRD Back to Search Results
Catalog Number RBYPOD6
Medical Device Problem Code Premature Separation (4045)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/25/2024
Type of Reportable Event Malfunction
Event or Problem Description
The patient was undergoing a coil embolization procedure in the renal artery using a pod coil and a lantern delivery microcatheter (lantern).During the procedure, while advancing the pod coil through the lantern, the physician noticed the pod coil had unintentionally detached.Therefore, the lantern containing the detached pod coil was removed.It was also reported that the physician decided to switch to a new microcatheter.The procedure was completed using a new pod coil and a new non-penumbra microcatheter.There was no report of an adverse effect to the patient.
 
Additional Manufacturer Narrative
Evaluation of the returned pod coil confirmed that the embolization coil was detached from its pusher assembly.If the pod coil is retracted against resistance, the pusher assembly may elongate beyond the reach of the pull wire and result in the embolization coil detachment.Based on the reported complaint, the root cause of resistance could not be determined.Further evaluation revealed that the pull wire protruded distal to the pusher assembly distal tip and the embolization coil had offset coil winds.This damage may have occurred during manipulated against resistance during the procedure.Further evaluation also revealed kinks on the pusher assembly and ovalization on the introducer sheath.This damage was incidental to the reported complaint and occurred during packaging for return to penumbra.Penumbra coils are visually inspected during in-process inspection and during quality inspection after manufacturing.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POD COIL
Common Device Name
HCG, KRD
Manufacturer (Section D)
PENUMBRA, INC.
one penumbra place
alameda CA 94502
Manufacturer Contact
veronica farris
one penumbra place
alameda, CA 94502
5107483200
MDR Report Key19797473
Report Number3005168196-2024-00256
Device Sequence Number7113792
Product Code HCG
UDI-Device Identifier00814548019611
UDI-Public00814548019611
Combination Product (Y/N)N
Initial Reporter StateWI
Initial Reporter CountryUS
PMA/510(K) Number
K173614
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 07/22/2024
Report Date (Section F) 01/01/2005
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberRBYPOD6
Device Lot NumberF113312
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/28/2024
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report to Manufacturer01/10/2005
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/25/2024
Initial Report FDA Received Date07/22/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/02/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age73 YR
Patient SexFemale
Date Report Sent to FDA01/01/2005
-
-